Clinical trial
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress - The ASPIRE-AF Trial
NCT03968393 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress - The ASPIRE-AF Trial
- Lead sponsor
- Population Health Research Institute
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 14, 2019
- Completion date
- December 31, 2028
- Enrollment
- 2,270 (estimated)
- Sites
- 105
Conditions
As the registry lists them; a condition with its own page is linked.